Discover 150 paid clinical trials in Savannah, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 150
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
1 location in Savannah
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
1 location in Savannah
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
National Cancer Institute "Cancer Moonshot Biobank"
for
Acute Myeloid Leukemia,
1 location in Savannah
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 13+
Code: NCT04314401
Recruiting
Active & Responsive
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
1 location in Savannah
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT06547489
Phase2, Recruiting
Active & Responsive
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
for
Major Depressive Disorder
1 location in Savannah
Sponsor: Cybin IRL Limited
Sex: All
Age: 18 - 70+
Code: NCT06564818
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
1 location in Savannah
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase2, Recruiting
Active & Responsive
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
for
Generalized Anxiety Disorder
1 location in Savannah
Sponsor: Definium Therapeutics US, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06741228
Phase3, Recruiting
Active & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
1 location in Savannah
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase2, Recruiting
Active & Responsive
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
1 location in Savannah
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18 - 65
Code: NCT06973577
Phase3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome